Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
about
Voltage-gated ion channels in cancer cell proliferationDiagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity.Role of epigenetics in EBV regulation and pathogenesis.Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis.Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies.Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.Quantitative trait association study for mean telomere length in the South Asian genomes.CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
P2860
Q27010511-C0BD4EF7-B6C2-4283-8CC1-1968D41E5201Q33603685-65DB620D-B260-416E-AF1B-61A6894792BBQ37714160-7F24F47C-E6C0-490B-B10D-DABEEAF90DE1Q38232195-F8D4358D-A6DA-4F87-B175-605D515362CFQ38262838-3A063F87-91BA-418C-A1CD-7DCB94813CF9Q38601598-AAD49905-FC8D-403D-87C4-4991123C81E2Q38667123-A91D0BCF-9195-43CD-8A09-E7CAE94D3844Q38905682-611AD1EE-37B2-41E1-9EA5-8166A83B45B0Q38931940-627EAC15-B088-4169-9FFE-971C763583B7Q40069599-57890F71-C41F-44D4-8A99-55BE1D1D678BQ48537480-2BAAFD94-805E-438F-8B5E-DDD1BC38339DQ58801315-739C42C9-A501-44F4-BF85-4326AF5C8926
P2860
Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Characterization of CACNA2D3 a ...... n of nasopharyngeal carcinoma.
@en
Characterization of CACNA2D3 a ...... n of nasopharyngeal carcinoma.
@nl
type
label
Characterization of CACNA2D3 a ...... n of nasopharyngeal carcinoma.
@en
Characterization of CACNA2D3 a ...... n of nasopharyngeal carcinoma.
@nl
prefLabel
Characterization of CACNA2D3 a ...... n of nasopharyngeal carcinoma.
@en
Characterization of CACNA2D3 a ...... n of nasopharyngeal carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Characterization of CACNA2D3 a ...... on of nasopharyngeal carcinoma
@en
P2093
Aikha Melissa Go Wong
Alissa Michelle Go Wong
Cailei Zhu
Janice Wing-hang Tsang
Kar Lok Kong
P2860
P304
P356
10.1002/IJC.28252
P577
2013-07-13T00:00:00Z